The safety of an adenosine A1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: Findings from PROTECT

John R. Teerlink, Vicente J. Iragui, Jay P. Mohr, Peter E. Carson, Paul J. Hauptman, David H. Lovett, Alan B. Miller, Ileana L. Piña, Scott Thomson, Paul D. Varosy, Michael R. Zile, John G.F. Cleland, Michael M. Givertz, Marco Metra, Piotr Ponikowski, Adriaan A. Voors, Beth A. Davison, Gad Cotter, Denise Wolko, Paul DeLuccaChristina M. Salerno, George A. Mansoor, Howard Dittrich, Christopher M. O'Connor, Barry M. Massie

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'The safety of an adenosine A1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: Findings from PROTECT'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds